Corient Private Wealth
RXDX

Corient Private Wealth’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Corient Private Wealth’s Portfolio RXDX Stock Details RXDX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-24,076
Closed -$2.58M – 2172
2023
Q1 		$2.58M Sell
24,076
-2,205
-8% -$237K 0.01% 763
2022
Q4 		$2.89M Buy
+26,281
New +$2.89M 0.01% 618